Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. ing. F.E. (Frits) Deiman

Publicaties

Deciphering Phospholamban Cardiomyopathy: Towards Precision Medicine for Genetic Heart Disease

Immune cell signature in non-ischemic heart failure indicates chronic systemic immune activation with features of immunosenescence

Nanoparticle-Mediated Delivery of Adenosine 5′-Monophosphate Enhances 5-Oxoprolinase Activity to Mitigate Oxidative Stress in Heart Failure

Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy

Plasma proteomics stratification identifies phospholamban R14del carriers at risk for disease progression

Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohort

RNA Therapeutics in Heart Failure

IL-17 is associated with disease severity and targetable inflammatory processes in heart failure

Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues

Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del

Pers/media

RNA therapy targets genetic cause of heart failure in the Netherlands

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijn

Meer informatie over de Sustainable Development Goals.